# Exploring Mechanisms and Morphology of QT Interval Prolongation

> **NCT03291145** · NA · COMPLETED · sponsor: **Herlev and Gentofte Hospital** · enrollment: 28 (actual)

## Conditions studied

- Long Qt Syndrome 1-2
- Sudden Cardiac Death

## Interventions

- **DRUG:** Beta Blockers
- **DRUG:** Spironolactone

## Key facts

- **NCT ID:** NCT03291145
- **Lead sponsor:** Herlev and Gentofte Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-27
- **Primary completion:** 2018-06-27
- **Final completion:** 2019-01-01
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2019-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03291145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03291145, "Exploring Mechanisms and Morphology of QT Interval Prolongation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03291145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*